Gabrielle Leclercq-Cohen (Gabrielle Leclercq)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Chronic Myeloid Leukemia

Cell Cycle Arrest

Tyrosine Kinase

Risk Assessment

Top Venues

Journal for immunotherapy of cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Gabrielle Leclercq-Cohen, Nathalie Steinhoff, Llucia Alberti Servera, Sina Nassiri, Sabrina Danilin, Emily Piccione, Emilio Yángüez, Tamara Hüsser, Sylvia Herter, Stephan Schmeing, Petra Gerber, Petra C Schwalie, Johannes Sam, Stefanie Briner, Silvia Jenni, Roberta Bianchi, Marlene Biehl, Floriana Cremasco, Katerina Apostolopoulou, Hélène Haegel, Christiane Neumann, Pablo Umaña, Marina Bacac
Dissecting the mechanisms underlying the Cytokine Release Syndrome (CRS) mediated by T Cell Bispecific Antibodies. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Gabrielle Leclercq-Cohen, Hélène Haegel, Anneliese Schneider, Anna Maria Giusti, Estelle Marrer-Berger, Christophe Boetsch, Antje-Christine Walz, Vesna Pulko, Johannes Sam, John Challier, Cristiano Ferlini, Alex Odermatt, Pablo Umaña, Marina Bacac, Christian Klein
Src/lck inhibitor dasatinib reversibly switches off cytokine release and T cell cytotoxicity following stimulation with T cell bispecific antibodies. Journal for immunotherapy of cancer 9 (7) (2022)
Gabrielle Leclercq-Cohen, Nathalie Steinhoff, Hélène Haegel, Donata De Marco, Marina Bacac, Christiane Neumann
Novel strategies for the mitigation of cytokine release syndrome induced by T cell engaging therapies with a focus on the use of kinase inhibitors. Oncoimmunology 11 (1) (2022)
Gabrielle Leclercq-Cohen, Hélène Haegel, Alberto Toso, Tina Zimmermann, Luke Green, Nathalie Steinhoff, Johannes Sam, Vesna Pulko, Anneliese Schneider, Anna Maria Giusti, John Challier, Anne Freimoser-Grundschober, Laurent Larivière, Alex Odermatt, Martin Stern, Pablo Umana, Marina Bacac, Christiane Neumann
JAK and mTOR inhibitors prevent cytokine release while retaining T cell bispecific antibody in vivo efficacy. Journal for immunotherapy of cancer 10 (1) (2022)
Gabrielle Leclercq-Cohen, Llucia Alberti Servera, Sabrina Danilin, John Challier, Nathalie Steinhoff, Claudia Bossen, Alex Odermatt, Valeria Nicolini, Pablo Umaña, Christiane Neumann, Marina Bacac, Anna-Maria Giusti, Anneliese Schneider, Hélène Haegel
Dissecting the mechanism of cytokine release induced by T-cell engagers highlights the contribution of neutrophils. Oncoimmunology 11 (1) (2022)